JP2010522212A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010522212A5 JP2010522212A5 JP2009554770A JP2009554770A JP2010522212A5 JP 2010522212 A5 JP2010522212 A5 JP 2010522212A5 JP 2009554770 A JP2009554770 A JP 2009554770A JP 2009554770 A JP2009554770 A JP 2009554770A JP 2010522212 A5 JP2010522212 A5 JP 2010522212A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- mesenchymal stem
- stem cells
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 11
- 241001465754 Metazoa Species 0.000 claims 9
- 208000019693 Lung disease Diseases 0.000 claims 7
- 210000004027 cell Anatomy 0.000 claims 4
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 3
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 3
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 3
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 3
- 208000002815 pulmonary hypertension Diseases 0.000 claims 3
- 230000037396 body weight Effects 0.000 claims 2
- 231100000241 scar Toxicity 0.000 claims 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 230000004199 lung function Effects 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 230000007115 recruitment Effects 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/726,676 US20080095749A1 (en) | 2004-03-22 | 2007-03-22 | Mesenchymal stem cells and uses therefor |
| PCT/US2008/057828 WO2008116157A2 (en) | 2007-03-22 | 2008-03-21 | Mesenchymal stem cells and uses therefor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014124452A Division JP5961220B2 (ja) | 2007-03-22 | 2014-06-17 | 間充織幹細胞とその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010522212A JP2010522212A (ja) | 2010-07-01 |
| JP2010522212A5 true JP2010522212A5 (enExample) | 2011-03-17 |
Family
ID=39735516
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009554770A Pending JP2010522212A (ja) | 2007-03-22 | 2008-03-21 | 間充織幹細胞とその使用 |
| JP2014124452A Active JP5961220B2 (ja) | 2007-03-22 | 2014-06-17 | 間充織幹細胞とその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014124452A Active JP5961220B2 (ja) | 2007-03-22 | 2014-06-17 | 間充織幹細胞とその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20080095749A1 (enExample) |
| EP (6) | EP2123747B1 (enExample) |
| JP (2) | JP2010522212A (enExample) |
| KR (7) | KR20250052468A (enExample) |
| CN (1) | CN101626772A (enExample) |
| BR (1) | BRPI0802241A2 (enExample) |
| CA (2) | CA3134185A1 (enExample) |
| DK (1) | DK2123747T3 (enExample) |
| ES (3) | ES2988291T3 (enExample) |
| WO (1) | WO2008116157A2 (enExample) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7682803B2 (en) | 2005-10-13 | 2010-03-23 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
| EP2824175B2 (en) | 2004-03-22 | 2020-10-28 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| US20050233443A1 (en) * | 2004-03-30 | 2005-10-20 | Toby Freyman | Restenosis therapy using mesenchymal stem cells |
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| WO2007039150A2 (en) | 2005-09-23 | 2007-04-12 | Cellerix, S.L. | Cell populations having immunoregulatory activity, method for isolation and uses |
| PT2471905T (pt) | 2005-12-29 | 2019-01-11 | Celularity Inc | Populações de células estaminais placentárias |
| US20070258963A1 (en) | 2006-01-13 | 2007-11-08 | Osiris Therapeutics, Inc. | Mesenchymal stem cells expressing TNF-alpha receptors |
| RS52921B (sr) | 2007-02-12 | 2014-02-28 | Anthrogenesis Corporation | Lečenje inflamatornih bolesti upotrebom placentnih matičnih ćelija |
| JP5541845B2 (ja) * | 2008-03-28 | 2014-07-09 | Jcrファーマ株式会社 | アトピー性皮膚炎治療剤 |
| US20110150845A1 (en) * | 2008-05-02 | 2011-06-23 | Massachusetts Institute Of Technology | Methods and compositions for modulating immunological tolerance |
| GB0814249D0 (en) * | 2008-08-04 | 2008-09-10 | Cellerix Sa | Uses of mesenchymal stem cells |
| CN105766891A (zh) | 2008-08-20 | 2016-07-20 | 人类起源公司 | 改进的细胞组合物及制备所述组合物的方法 |
| CA2965883C (en) | 2008-08-22 | 2020-05-12 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
| EP2346358A4 (en) * | 2008-10-05 | 2013-11-27 | Hymie Friedlander | EXTRACT OF ON THE BASIS OF REGENERATIVE CELLS CULTURED CONDITIONED MEDIUM |
| ES2749500T3 (es) | 2008-11-19 | 2020-03-20 | Celularity Inc | Células adherentes derivadas del amnios |
| CN104962512B (zh) * | 2009-07-21 | 2022-09-09 | Abt控股公司 | 干细胞用于减少白细胞外渗的用途 |
| WO2011070974A1 (ja) * | 2009-12-07 | 2011-06-16 | 国立大学法人名古屋大学 | 脂肪組織由来間葉系幹細胞を含有する、前立腺癌治療用細胞製剤 |
| WO2011072399A1 (en) * | 2009-12-18 | 2011-06-23 | The Governing Council Of The University Of Toronto | Injectable polymer composition for use as a cell delivery vehicle |
| MX2012011543A (es) | 2010-04-08 | 2013-05-06 | Anthrogenesis Corp | Tratamiento de sarcoidosis empleando celulas madre placentarias. |
| KR101677293B1 (ko) * | 2010-04-16 | 2016-11-17 | 서울대학교병원 | 줄기세포의 활성을 증가시키는 방법 및 상기 방법에 의해 제조된 고활성 줄기 세포 |
| SG185526A1 (en) | 2010-05-12 | 2012-12-28 | Abt Holding Co | Modulation of splenocytes in cell therapy |
| WO2012048099A2 (en) * | 2010-10-08 | 2012-04-12 | Osiris Therapeutics, Inc. | Nanoparticle-loaded cells |
| CN101991878A (zh) * | 2010-11-08 | 2011-03-30 | 中国人民解放军军事医学科学院基础医学研究所 | 由复合msc的plga和msc组成的制剂及其应用 |
| CN101991880A (zh) * | 2010-11-08 | 2011-03-30 | 中国人民解放军军事医学科学院基础医学研究所 | 由复合msc的plga/tcp和msc组成的制剂及其应用 |
| WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
| ES2629502T3 (es) * | 2011-03-11 | 2017-08-10 | Children's Medical Center Corporation | Métodos y composiciones relacionados con exosomas de células madre mesenquimales |
| WO2012166844A2 (en) | 2011-06-01 | 2012-12-06 | Anthrogenesis Corporation | Treatment of pain using placental stem cells |
| TWI812867B (zh) * | 2011-11-30 | 2023-08-21 | 安斯泰來再生醫藥協會 | 利用血管母細胞產生間葉基質細胞之方法 |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| CN103191154B (zh) * | 2012-01-06 | 2015-09-09 | 上海交通大学医学院 | 充质干细胞及其提取方法在制备银屑病的药物中的应用 |
| US20150110751A1 (en) * | 2012-05-16 | 2015-04-23 | Kennedy Krieger Institute, Inc. | Stem cells as an individualized maternal therapy for prevention of prematurity |
| CA2876499C (en) | 2012-07-12 | 2021-10-26 | Imstem Biotechnology, Inc. | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |
| AU2013360026B2 (en) * | 2012-12-12 | 2018-06-21 | Mesoblast, Inc. | Methods of treating or preventing respiratory conditions |
| SG10201705061RA (en) * | 2012-12-12 | 2017-07-28 | Mesoblast Inc | Treatment of Diseases of Endothelial Dysfunction and Inflammation |
| WO2014100857A1 (en) * | 2012-12-24 | 2014-07-03 | Cell Ideas Pty Ltd | Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
| US10149864B2 (en) * | 2013-03-13 | 2018-12-11 | The University Of Queensland | Method of isolating cells for therapy and prophylaxis |
| CA2909267C (en) | 2013-04-12 | 2022-10-25 | Saverio LA FRANCESCA | Improving organs for transplantation |
| US20160120910A1 (en) * | 2013-06-25 | 2016-05-05 | Tigenix S.A.U. | Cell populations having immunoregulatory activity, methods for the preparation and uses thereof |
| US20160245825A1 (en) * | 2013-10-04 | 2016-08-25 | Cell Ideas Pty Ltd | Biomarkers for Cell Therapy |
| JP6210049B2 (ja) | 2014-11-04 | 2017-10-11 | トヨタ自動車株式会社 | 車両 |
| AU2016206033B2 (en) * | 2015-01-08 | 2022-06-16 | Apceth Gmbh & Company Kg | Genetically modified mesenchymal stem cells expressing Alpha-1 antitrypsin (AAT) |
| WO2016146819A1 (en) * | 2015-03-18 | 2016-09-22 | Apceth Gmbh & Co. Kg | Hypoxia-induced expression of therapeutic proteins in mesenchymal stem cells |
| US10746729B2 (en) * | 2015-04-24 | 2020-08-18 | Tigenix, S.A.U. | Biomarkers for determining the clinical response to cell therapy |
| CA3001154C (en) | 2015-10-07 | 2023-10-17 | Sangui Bio Pty. Ltd | Blood preparation and profiling |
| EP3393482A4 (en) * | 2015-12-22 | 2019-08-21 | Sangui Bio Pty. Ltd | THERAPEUTIC PROCEDURES USING ERYTHROCYTES |
| GB201604304D0 (en) | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| CN105769911A (zh) * | 2016-03-23 | 2016-07-20 | 中国人民解放军第二军医大学 | 间充质干细胞诱导斑秃处毛发再生的方法及应用 |
| KR101970642B1 (ko) * | 2016-04-06 | 2019-05-17 | 주식회사 제이제이메이딘 | 줄기세포 배양용 배지조성물 및 그를 이용한 줄기세포 배양방법 |
| WO2017188403A1 (ja) | 2016-04-27 | 2017-11-02 | ロート製薬株式会社 | Cd201、cd46、cd56、cd147及びcd165からなる群より選択される少なくとも1種の細胞表面マーカーを発現する間葉系幹細胞及びその調製方法、並びに上記間葉系幹細胞を含む医薬組成物及びその調製方法 |
| US20210283183A1 (en) | 2016-08-05 | 2021-09-16 | Exostemtech Co., Ltd. | Composition for preventing or treating pulmonary fibrosis containing exosome isolated from adipose-derived stem cell as active ingredient |
| WO2018092769A1 (ja) | 2016-11-15 | 2018-05-24 | 株式会社カネカ | 胎児付属物に由来する間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物 |
| CN106492194A (zh) * | 2016-11-30 | 2017-03-15 | 广州赛莱拉干细胞科技股份有限公司 | 一种干细胞外泌体制剂及其制备方法和应用 |
| AU2017379367B2 (en) | 2016-12-20 | 2023-12-07 | Sangui Bio Pty. Ltd | Blood profiling with protease inhibitors |
| WO2018151046A1 (ja) * | 2017-02-15 | 2018-08-23 | ロート製薬株式会社 | 肺線維症治療剤、ptprr発現促進剤及び肺線維症治療用キット |
| AU2018234827B2 (en) | 2017-03-15 | 2024-04-04 | Orca Biosystems Inc. | Compositions and methods for hematopoietic stem cell transplants |
| EP3714038A1 (en) | 2017-11-22 | 2020-09-30 | Mesoblast International Sàrl | Cellular compositions and methods of treatment i |
| CN111527198A (zh) | 2017-12-28 | 2020-08-11 | 株式会社钟化 | 包含贴壁性干细胞的细胞群、其制造方法、以及医药组合物 |
| CN108451981B (zh) * | 2018-04-21 | 2019-07-23 | 江西汉氏联合干细胞科技有限公司 | 使用皮肤间充质干细胞治疗系统性硬化症 |
| WO2020015264A1 (zh) * | 2018-07-17 | 2020-01-23 | 北京三有利和泽生物科技有限公司 | 牙源干细胞及其用途 |
| JP7572367B2 (ja) * | 2019-03-12 | 2024-10-23 | ベーリンガー インゲルハイム ヴェテリナリー メディスン ベルギー | 免疫調節性間葉系幹細胞 |
| WO2020190094A1 (ko) * | 2019-03-21 | 2020-09-24 | (주)안트로젠 | 중간엽줄기세포-하이드로겔을 함유하는 주사형 조성물 및 이의 제조, 동결 및 해동방법 |
| EP3984596A4 (en) | 2019-06-14 | 2023-06-21 | Kaneka Corporation | POPULATION OF CELLS COMPRISING MESENCHYMATOUS CELLS, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND METHOD FOR PRODUCTION THEREOF |
| CN110772537A (zh) * | 2019-11-07 | 2020-02-11 | 深圳科康干细胞技术有限公司 | 脐带血间充质干细胞组合物在治疗慢性阻塞性肺疾病中的应用 |
| WO2021176001A1 (en) * | 2020-03-05 | 2021-09-10 | Mesoblast International Sàrl | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells |
| CA3173216A1 (en) * | 2020-04-03 | 2021-10-07 | Silviu Itescu | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells |
| US20210315937A1 (en) * | 2020-04-08 | 2021-10-14 | University Of South Florida | Methods of treating inflammation |
| CA3182658A1 (en) | 2020-05-08 | 2021-11-11 | Gallant Pet, Inc. | Uterine-derived regenerative cell compositions and uses thereof |
| EP3909594A1 (en) * | 2020-05-14 | 2021-11-17 | Bernat Soria Escoms | Mesenchymal stromal cells for the treatment of covid-19 and other inflammatory, autoimmune and degenerative diseases |
| CN111568930A (zh) * | 2020-05-23 | 2020-08-25 | 湖南源品细胞生物科技有限公司 | 一种msc用于调节nk细胞数量的应用 |
| IL299997A (en) * | 2020-07-20 | 2023-03-01 | Brainstorm Cell Therapeutics Ltd | Methods and preparations for the treatment of lung conditions |
| CN112076217A (zh) * | 2020-10-26 | 2020-12-15 | 重庆医科大学附属第一医院 | 一种间充质干细胞来源的抗炎症氧化脂质组合物的制备方法 |
| AU2023323861A1 (en) * | 2022-08-11 | 2025-02-27 | Boehringer Ingelheim Vetmedica Gmbh | Mesenchymal stem cells for use in the treatment of insect-bite hypersensitivity in equines |
| CN117398450B (zh) * | 2023-10-31 | 2025-03-11 | 北京三有利和泽生物科技有限公司 | 过表达肝细胞生长因子的间充质干细胞在制备哮喘药物中的应用 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
| US5843425A (en) * | 1992-02-19 | 1998-12-01 | The General Hospital Corporation | Transplantation and graft-versus-host-disease |
| WO1993018648A1 (en) * | 1992-03-23 | 1993-09-30 | Baxter International Inc. | In vitro-derived human neutrophil precursor cells |
| US6974571B2 (en) * | 1995-03-28 | 2005-12-13 | Thomas Jefferson University | Isolated stromal cells and methods of using the same |
| US6077987A (en) * | 1997-09-04 | 2000-06-20 | North Shore-Long Island Jewish Research Institute | Genetic engineering of cells to enhance healing and tissue regeneration |
| ATE286118T1 (de) * | 1998-03-13 | 2005-01-15 | Osiris Therapeutics Inc | Anwendungen für humane nicht autologe, mesenchymale stammzellen |
| WO1999047163A2 (en) * | 1998-03-18 | 1999-09-23 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| US20030118567A1 (en) * | 1999-03-26 | 2003-06-26 | Stewart Duncan John | Cell-based therapy for the pulmonary system |
| PT1066060E (pt) * | 1998-04-03 | 2003-12-31 | Osiris Therapeutics Inc | Celulas estaminais mesenquimais como imunossupressores |
| US6835377B2 (en) * | 1998-05-13 | 2004-12-28 | Osiris Therapeutics, Inc. | Osteoarthritis cartilage regeneration |
| ATE382681T1 (de) * | 1998-07-31 | 2008-01-15 | Genzyme Corp | Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen |
| WO2002008389A2 (en) * | 2000-07-26 | 2002-01-31 | Scimed Life Systems, Inc. | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| US20020045260A1 (en) * | 2000-10-17 | 2002-04-18 | Shih-Chieh Hung | Method of isolating mesenchymal stem cells |
| US6905678B2 (en) * | 2001-07-07 | 2005-06-14 | Crucell Holland B.V. | Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| EP1474156A4 (en) * | 2002-01-14 | 2009-06-17 | Ford Henry Health System | MATERIALS FROM BONE MARROW CALVES FOR USE IN THE PROCESSING OF BLOOD VESSELS AND THE PRODUCTION OF ANGIOGENIC AND TROPHIC FACTORS |
| US6974991B2 (en) * | 2003-10-29 | 2005-12-13 | International Business Machines Corp. | DRAM cell with buried collar and self-aligned buried strap |
| EP2824175B2 (en) * | 2004-03-22 | 2020-10-28 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| JP4326462B2 (ja) * | 2004-11-19 | 2009-09-09 | 富士通株式会社 | 半導体集積回路の設計を支援する設計支援装置、設計支援プログラム、及び設計支援方法 |
| JP5162756B2 (ja) * | 2005-04-14 | 2013-03-13 | 財団法人ヒューマンサイエンス振興財団 | 医薬組成物及びその製造方法 |
| TWM290409U (en) * | 2005-10-14 | 2006-05-11 | Ming Shiau | Retractable barbeque rack |
| US20070253931A1 (en) * | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
| US20070178073A1 (en) * | 2006-02-01 | 2007-08-02 | Samsung Life Public Welfare Foundation | Composition Comprising Separated or Proliferated Cells from Umbilical Cord Blood for Treating Developmental and/or Chronic Lung Disease |
| US20090274665A1 (en) * | 2006-04-27 | 2009-11-05 | Cell Therapy Technologies, Inc. | Stem Cells For Treating Lung Diseases |
| CA2674028C (en) | 2008-07-25 | 2012-09-04 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence | Recombinant b. pseudomallei adhesin protein and methods and uses thereof |
-
2007
- 2007-03-22 US US11/726,676 patent/US20080095749A1/en not_active Abandoned
-
2008
- 2008-03-21 WO PCT/US2008/057828 patent/WO2008116157A2/en not_active Ceased
- 2008-03-21 CN CN200880000168A patent/CN101626772A/zh active Pending
- 2008-03-21 CA CA3134185A patent/CA3134185A1/en active Pending
- 2008-03-21 EP EP09009947.4A patent/EP2123747B1/en active Active
- 2008-03-21 KR KR1020257010916A patent/KR20250052468A/ko active Pending
- 2008-03-21 EP EP24190629.6A patent/EP4438721A3/en active Pending
- 2008-03-21 KR KR1020087025381A patent/KR20090122415A/ko not_active Ceased
- 2008-03-21 EP EP19204349.5A patent/EP3653217B1/en active Active
- 2008-03-21 CA CA2637157A patent/CA2637157C/en active Active
- 2008-03-21 ES ES21195085T patent/ES2988291T3/es active Active
- 2008-03-21 KR KR1020167004407A patent/KR20160027230A/ko not_active Ceased
- 2008-03-21 KR KR1020197007767A patent/KR102357942B1/ko active Active
- 2008-03-21 EP EP21195085.2A patent/EP3973970B1/en active Active
- 2008-03-21 KR KR1020227002865A patent/KR102519603B1/ko active Active
- 2008-03-21 BR BRPI0802241-0A patent/BRPI0802241A2/pt not_active Application Discontinuation
- 2008-03-21 JP JP2009554770A patent/JP2010522212A/ja active Pending
- 2008-03-21 EP EP08744188A patent/EP2051718A2/en not_active Withdrawn
- 2008-03-21 ES ES19204349T patent/ES2891574T3/es active Active
- 2008-03-21 DK DK09009947.4T patent/DK2123747T3/en active
- 2008-03-21 ES ES16171424T patent/ES2765650T3/es active Active
- 2008-03-21 KR KR1020247000248A patent/KR20240008404A/ko not_active Ceased
- 2008-03-21 EP EP16171424.1A patent/EP3095450B1/en active Active
- 2008-03-21 US US12/091,370 patent/US20090220464A1/en not_active Abandoned
- 2008-03-21 KR KR1020227042287A patent/KR20220166876A/ko not_active Ceased
-
2010
- 2010-08-25 US US12/868,415 patent/US20100330048A1/en not_active Abandoned
-
2014
- 2014-06-17 JP JP2014124452A patent/JP5961220B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010522212A5 (enExample) | ||
| JP2011144201A5 (enExample) | ||
| JP2011511006A5 (ja) | 肺病態に対する医薬組成物 | |
| JP2013040176A5 (enExample) | ||
| HRP20130052T1 (hr) | Lijeäśenje respiratorne bolesti | |
| HRP20140657T1 (hr) | Laminin-1 za primjenu radi pojaäśanja regeneracije mišiä†a nakon ozljede ili za bolje zacjeljivanje rana ako se daje sistemski | |
| JP2020532531A5 (enExample) | ||
| JP2024010006A5 (enExample) | ||
| JP2018009002A5 (enExample) | ||
| JP2010500291A5 (enExample) | ||
| JP2018502579A5 (enExample) | ||
| JP2015511625A5 (enExample) | ||
| JP2008516991A5 (enExample) | ||
| UY30935A1 (es) | Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones. | |
| JP2016510040A5 (enExample) | ||
| JP2012502105A5 (enExample) | ||
| JP2012525422A5 (enExample) | ||
| JP2011012060A5 (enExample) | ||
| JP2010523662A5 (enExample) | ||
| JP2008534621A5 (enExample) | ||
| JP2017524732A5 (enExample) | ||
| JP2013522295A5 (enExample) | ||
| RU2008102655A (ru) | Введение в дыхательные пути ингибитора тканевого фактора при воспалительных состояниях, поражающих дыхательные пути | |
| Araújo et al. | Transitory increased blood pressure after upper airway surgery for snoring and sleep apnea correlates with the apnea-hypopnea respiratory disturbance index | |
| CN101167839B (zh) | 治疗和预防慢性阻塞性肺病的金荞麦复方制剂及用途 |